PF-06873600

An inhibitor of Cdk2, Cdk4, and Cdk6

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
5mg

￥5875.00

4700.00

- +
10mg

￥9087.00

7270.00

- +
25mg

￥18525.00

14820.00

- +
50mg

￥29137.00

23310.00

- +
100mg

￥41850.00

33480.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

Background

PF-06873600 is an inhibitor of cyclin-dependent kinase 2 (Cdk2), Cdk4, and Cdk6 (K_is = 0.13, 1.25, and 0.11 nM, respectively).¹ It is selective for these CDKs over Cdk1 and Cdk9 (K_is = 4.5 and 19.6 nM, respectively). PF-06873600 inhibits the phosphorylation of RB transcriptional corepressor 1 (RB1) in, and the proliferation of, OVCAR-3 ovarian cancer cells (EC₅₀s = 19 and 45 nM, respectively). In vivo, PF-06873600 (30 mg/kg) reduces tumor volume in CTG-0464 and CTG-01912 non-small cell lung cancer (NSCLC) patient-derived xenograft (PDX) mouse models.

1.Freeman-Cook, K.D., Hoffman, R.L., Behenna, D.C., et al.Discovery of PF-06873600, a CDK2/4/6 inhibitor for the treatment of cancerJ. Med. Chem.64(13)9056-9077(2021)